mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development

After the genome sequence of SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) was published and the number of infected people began to increase rapidly, many global companies began to develop a vaccine. Almost all known approaches to vaccine design were applied for this purpose,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilyichev, A.A., Orlova, L.A., Sharabrin, S.V., Karpenko, L.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094037/
https://www.ncbi.nlm.nih.gov/pubmed/33959697
http://dx.doi.org/10.18699/VJ20.676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094037/
https://www.ncbi.nlm.nih.gov/pubmed/33959697
http://dx.doi.org/10.18699/VJ20.676

Ejemplares similares